Health news
The Food and Drug Administration (FDA) has approved the supplemental Biologics License Application for Vaxneuvance (pneumococcal 15-valent conjugate vaccine) for the prevention of invasive pneumococcal disease in pediatric patients 6 weeks through 17 years of…
In adolescents, researchers found an association between brain activity in the ventral striatum (VS) region and depression, and that activity changes over time, according to a study published in the American Journal of Psychiatry. Researchers…
Children suspected of having autism spectrum disorder (ASD) should be evaluated for co-occurring motor and structural language deficits, according study findings published in Research in Developmental Disabilities. ASD is a neurodevelopmental disorder marked by highly…
The Food and Drug Administration (FDA) has approved the supplemental New Drug Application (sNDA) for Imcivree® (setmelanotide) for chronic weight management in patients 6 years of age and older with monogenic or syndromic obesity due…
Following a unanimous vote of support by the Food and Drug Administration’s (FDA) Vaccines and Related Biological Products Advisory Committee, the FDA has authorized the emergency use of the Moderna COVID-19 Vaccine and the Pfizer-BioNTech…
The Food and Drug Administration’s (FDA) Vaccines and Related Biological Products Advisory Committee met this week to discuss amending the Emergency Use Authorizations (EUA) of the Moderna COVID-19 Vaccine to include the administration of the…
Adolescent boys with autism spectrum disorder (ASD) may be at higher risk for self-harm, according to results of a study, published in BMC Medicine. Self-harm among adolescents is 1 of the strongest predictors for future…
The Food and Drug Administration (FDA) has expanded the approval of CellCept (mycophenolate mofetil) to include prophylaxis of organ rejection in pediatric recipients of allogeneic heart and liver transplants. CellCept is now indicated for the…
The Food and Drug Administration (FDA) has approved Dupixent® (dupilumab) for the treatment of moderate to severe atopic dermatitis in pediatric patients aged 6 months to 5 years whose disease is not adequately controlled with…
Once-weekly treatment with dulaglutide was found to improve glycemic control in adolescents with uncontrolled type 2 diabetes (T2D), according to data presented at the 82nd Scientific Sessions of the American Diabetes Association. Dulaglutide is a…
© 2005-2021 Top-Meds - All rights reserved. Our website services, content, and products are for informational purposes only. Top-Meds does not provide medical advice, diagnosis, or treatment. | Medical News 2021